selegiline has been researched along with Anterior Choroidal Artery Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haapalinna, A; Jolkkonen, J; Kauppinen, R; Nyman, L; Sivenius, J | 1 |
| Bolay, H; Dalkara, T; Gürsoy-Ozdemir, Y; Saribaş, O; Söylemezoglu, F; Unal, I | 1 |
2 other study(ies) available for selegiline and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
MAO-B inhibition by a single dose of l-deprenyl or lazabemide does not prevent neuronal damage following focal cerebral ischaemia in rats.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurons; Picolinic Acids; Rats; Rats, Wistar; Selegiline | 2000 |
Chronic daily administration of selegiline and EGb 761 increases brain's resistance to ischemia in mice.
Topics: Actins; Animals; Apoptosis; Brain; Brain Ischemia; Caspases; Cerebral Infarction; Drug Administration Schedule; Ginkgo biloba; Immunity, Innate; In Situ Nick-End Labeling; Mice; Neurons; Neuroprotective Agents; Plant Extracts; Selegiline | 2001 |